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Clinical PerspectiveWhat Is New?This is the first study to examine the relationship between telomere length and vascular structure and function in a population‐based cohort of children and adults.In midlife adults, but not children, there was some evidence that telomere length was associated with vascular elasticity.The novel small association between longer telomere length and higher carotid elasticity in adults is interesting; however, the strength of the association could equally be caused by chance and, hence, requires replication.What Are the Clinical Implications?The clinical utility of cross‐sectional telomere length assessment for cardiovascular disease risk in healthy populations of children or midlife adults is limited.Future studies should consider longitudinal associations of telomere length with vascular phenotypes and cardiovascular events.

Introduction {#jah34147-sec-0008}
============

Given the global burden of cardiovascular disease (CVD), considerable efforts are under way to understand the underlying cause and to identify potential biomarkers predictive of risk.[1](#jah34147-bib-0001){ref-type="ref"} Cell senescence may play an important role in the progression of CVD, although the upstream drivers of CVD‐associated cell death remain to be fully elucidated. One well‐studied pathway to cellular senescence is mediated via telomere shortening. Telomeres are nucleoprotein structures that cap the ends of linear chromosomes. Their shortening represents a molecular mechanism of biological aging[2](#jah34147-bib-0002){ref-type="ref"} and occurs because of the general inability of cells to replicate the ends of linear DNA in the absence of telomerase. At a critical length, the DNA damage response drives cell senescence, resulting in inhibited tissue repair capacity and function.

Considerable evidence has linked shorter telomeres with greater risk of all‐cause mortality,[3](#jah34147-bib-0003){ref-type="ref"} cancer,[4](#jah34147-bib-0004){ref-type="ref"} infectious disease,[5](#jah34147-bib-0005){ref-type="ref"} and CVD.[6](#jah34147-bib-0006){ref-type="ref"}, [7](#jah34147-bib-0007){ref-type="ref"} Notably, a meta‐analysis of 43 725 adults (mean age, 60 years) showed that those with the shortest telomeres in blood had a 30% to 83% higher risk of coronary artery disease relative to those with the longest telomeres.[6](#jah34147-bib-0006){ref-type="ref"} Recent studies in adults have shown accelerated telomere shortening in blood cells from patients with atherosclerosis.[8](#jah34147-bib-0008){ref-type="ref"}, [9](#jah34147-bib-0009){ref-type="ref"} Few studies have explored this relationship in relatively healthy populations of younger individuals, despite the fact that the pathways to cardiometabolic ill health in adulthood begin much earlier in life.[1](#jah34147-bib-0001){ref-type="ref"} Telomere‐linked cell senescence may be on the mechanistic pathway to poor cardiovascular health, or it may represent a critical "tipping point" in the life course when overt CVD emerges.

Noninvasive measures of vascular phenotypes enable assessment of cardiovascular structure and function in the large arteries. Ultrasound and tonometry of the carotid artery can capture carotid intima‐media thickness (IMT),[10](#jah34147-bib-0010){ref-type="ref"}, [11](#jah34147-bib-0011){ref-type="ref"} carotid‐femoral pulse‐wave velocity (PWV), and carotid elasticity.[12](#jah34147-bib-0012){ref-type="ref"}, [13](#jah34147-bib-0013){ref-type="ref"}, [14](#jah34147-bib-0014){ref-type="ref"} Carotid IMT is a validated structural marker of subclinical atherosclerosis and correlates with total atherosclerotic burden in adults.[15](#jah34147-bib-0015){ref-type="ref"} Faster carotid‐femoral PWV and reduced carotid elasticity are functional measures of arterial stiffness[14](#jah34147-bib-0014){ref-type="ref"} linked to higher risk of cardiovascular events.[16](#jah34147-bib-0016){ref-type="ref"} Thicker carotid IMT has previously been associated with shorter telomeres in clinical samples of older adults.[17](#jah34147-bib-0017){ref-type="ref"}, [18](#jah34147-bib-0018){ref-type="ref"} However, recent studies of healthy adults in late life showed that telomere length was not associated with carotid IMT[19](#jah34147-bib-0019){ref-type="ref"} or with carotid atherosclerosis.[20](#jah34147-bib-0020){ref-type="ref"} Functional measures have also been linked with shortened telomeres in later‐life adults.[21](#jah34147-bib-0021){ref-type="ref"}, [22](#jah34147-bib-0022){ref-type="ref"}

Although telomere length may be a potential mechanism underlying CVD across the life course, studies are conflicting[6](#jah34147-bib-0006){ref-type="ref"} and little is known of the relationship in younger adults or children. It may be that telomere length is associated with vascular function earlier than structural phenotypes.[23](#jah34147-bib-0023){ref-type="ref"} Thus, exploring the relationship of telomere length with functional and structural phenotypes across the life course could enhance our understanding of the role of telomere length‐driven cell senescence in the pathogenesis of CVD. We aimed to assess the associations of telomere length with measures of vascular structure and function in a population‐based cross‐sectional study of children and their parents.

Materials and Methods {#jah34147-sec-0009}
=====================

The data that support the findings of this study are available from the corresponding author on reasonable request.

Study Design and Participants {#jah34147-sec-0010}
-----------------------------

The LSAC (Longitudinal Study of Australian Children) recruited a nationally representative birth cohort in 2004 (n=5107). Participants have been followed up at 7 biennial waves spanning birth to 13 years. The CheckPoint (Child Health CheckPoint) study was an additional physical health and biomarker wave for the birth cohort, nested between LSAC\'s sixth and seventh waves. During the LSAC wave 6 assessment in 2014, interviewers obtained written consent from 3513 families (93% of the 3764 seen) to be contacted to participate in the upcoming CheckPoint study. Ultimately, 1874 adult‐child pairs (50%) took part. Most nonparticipation (60%) was caused by inability to attend or to reschedule a visit during the short period CheckPoint study was in each location. Details of the LSAC and CheckPoint study design and recruitment have been previously described,[24](#jah34147-bib-0024){ref-type="ref"}, [25](#jah34147-bib-0025){ref-type="ref"}, [26](#jah34147-bib-0026){ref-type="ref"}, [27](#jah34147-bib-0027){ref-type="ref"} and the [Figure](#jah34147-fig-0001){ref-type="fig"} shows the flow through the study.

![LSAC (Longitudinal Study of Australian Children) and CheckPoint (Child Health CheckPoint) study participant flow.](JAH3-8-e012707-g001){#jah34147-fig-0001}

Data collection ran from February 2015 to March 2016. The CheckPoint study Assessment Center operated sequentially across Australia in major cities (3.5 hours, main center) and regional centers (2.5 hours, minicenter), with home visits offered to those unable to attend a center. Children and their attending parent rotated through a series of 15‐minute stations, in which different aspects of health were assessed and biological samples were collected, including venous blood. A trained researcher undertook cardiovascular measures while medically trained researchers or phlebotomists collected venous blood. Samples were processed and cryopreserved within 2 hours on site. For the first 2 months, this included blood clots from plasma tubes; for logistic reasons, clots were then discontinued and replaced with a whole blood sample for the remaining centers. As each assessment center closed, samples were transported to the Murdoch Children\'s Research Institute in Melbourne, Australia, where they remain cryopreserved until depletion. The logistics and specified requirements of this large, national, government‐owned population‐based cohort precluded any participants attending repeated sessions. However, all values for all participants in both age groups are based on repeated measurements within the same session, as are the interobserver and intraobserver ratings for the observer‐dependent measurements (carotid IMT and waveform quality ratings). Previous studies have confirmed similar repeatability between children and adults,[28](#jah34147-bib-0028){ref-type="ref"}, [29](#jah34147-bib-0029){ref-type="ref"} and between sessions separated by hours to weeks.[30](#jah34147-bib-0030){ref-type="ref"}

The study was approved by the Royal Children\'s Hospital Melbourne Human Research Ethics Committee (33225D) and the Australian Institute of Family Studies Ethics Committee (14‐26). The attending parents provided written informed consent for themselves and their child before participation, and the child provided assent.

DNA Isolation and Telomere Length Measurement {#jah34147-sec-0011}
---------------------------------------------

Genomic DNA was isolated from available blood using the QIAamp 96 DNA Blood Kit (Qiagen, Venlo, the Netherlands). Purity and integrity was confirmed using the NanoDrop 2000 Spectrophotometer (NanoDrop Technologies, Middleton, WI), the Qubit 2.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA), and gel electrophoresis. Telomere length was measured with the quantitative real‐time polymerase chain reaction method, originally described by Cawthon.[31](#jah34147-bib-0031){ref-type="ref"} This method measures the amount of telomeric genomic DNA (T)/β‐globin single‐copy gene (S) (T/S ratio) for each participant. The mean intra‐assay variability between "T" and "S" quadruplicates used in the calculation of the T/S ratio was 1.7% (SD, 0.3%; range, 0.9%--2.6%). The interassay variability between plates was 1.7% (SD, 1.4%; range, 0.3%--6.2%). Further details on the telomere length calculation (Table [S1](#jah34147-sup-0001){ref-type="supplementary-material"}), plate conditions, and constituents are described in Data [S1](#jah34147-sup-0001){ref-type="supplementary-material"} and in the Standard Operating Procedure on the CheckPoint study\'s website.[32](#jah34147-bib-0032){ref-type="ref"}, [33](#jah34147-bib-0033){ref-type="ref"}

Carotid IMT and Carotid Elasticity {#jah34147-sec-0012}
----------------------------------

Carotid IMT and elasticity were measured using standardized protocols via ultrasound (Vivid i BT06 with 10‐MHz linear array probe; GE Healthcare, Little Chalfont, UK).[10](#jah34147-bib-0010){ref-type="ref"}, [11](#jah34147-bib-0011){ref-type="ref"} Ultrasounds were performed in supine position with head turned 45° to the left. The ultrasound probe was applied to the right side of the neck at ≈45° to the midline with concurrent 3‐lead ECG trace. The duration of the captured real‐time B‐mode ultrasound cine loops was 10 cardiac cycles.

All images were reviewed for quality to select optimal loops comprising a clear near and far wall intima‐media, clear lumen, straight vessel, presence of the carotid bulb, and an ECG trace. The best‐quality 5 to 7 cardiac cycle section of the loops was trimmed and extracted. These loops were further processed using Carotid Analyzer (Medical Imaging Applications, Coralville, IA). Raters calibrated the images using ultrasound image markers. Maximum carotid IMT values were used in analyses, which refer to the 3 to 5 frame average of the thickest point of carotid IMT measurement over the highest quality 5‐ to 10‐mm section from the carotid bulb. After algorithmic detection of the intima‐media interface over the entire cine‐loop, frames were manually adjusted as needed or rejected if the intima‐media interface was unclear or blurred. The intraobserver variability for the maximum carotid IMT values was 4.9% (95% CI, 4.6%--5.2%), and the interobserver variability was 6.2% (95% CI, 5.2%--7.2%). Further details are described elsewhere.[25](#jah34147-bib-0025){ref-type="ref"}, [34](#jah34147-bib-0034){ref-type="ref"}

Carotid elasticity was calculated from carotid artery images and expressed as a percentage change in intima‐intima lumen diameter (measured from ultrasound) per change in pulse pressure (measured from SphygmoCor), as previously described (Table [S1](#jah34147-sup-0001){ref-type="supplementary-material"}).[13](#jah34147-bib-0013){ref-type="ref"} Intima‐intima lumen diameter measurement was automated using Carotid Analyzer and, thus, was rater independent; it was calculated by measuring the average intima‐intima distance (subtracting near and far wall IMT measurements) on each of the 3 to 5 still frames used to calculate maximum carotid IMT. Intraobserver and interobserver variability values for maximum lumen diameter were 1.3% (95% CI, 1.2%--1.4%) and 1.6% (95% CI, 1.4%--1.9%), respectively; and values for minimum lumen diameter were 1.2% (95% CI, 1.1%--1.3%) and 1.5% (95% CI, 1.2%--1.7%), respectively. Further details are in Data [S1](#jah34147-sup-0001){ref-type="supplementary-material"} and prior publications.[25](#jah34147-bib-0025){ref-type="ref"}, [34](#jah34147-bib-0034){ref-type="ref"}

Carotid‐Femoral PWV and Blood Pressure {#jah34147-sec-0013}
--------------------------------------

Carotid‐femoral PWV and blood pressure were measured using tonometry via SphygmoCor XCEL (AtCor Medical, West Ryde, Australia), as previously described.[14](#jah34147-bib-0014){ref-type="ref"} Carotid‐femoral PWV was determined by detecting waveforms simultaneously by a hand‐held tonometer at the carotid pulse and a cuff placed on the proximal thigh, over a 10‐second period. This was completed 3 times in the supine position. The distance traveled by waveforms was measured with a tape measure from the carotid pulse to the suprasternal notch, from the suprasternal notch to the right femoral pulse, and from the femoral pulse to the top of the thigh cuff. The mean of at least 2 valid carotid‐femoral PWV measurements (in m/s) was used in analyses. Systolic and diastolic blood pressure values were recorded at the brachial artery, 3 times, 1 minute apart, with either a 23‐ to 33‐cm or a 31‐ to 40‐cm cuff, depending on arm size. Systolic and diastolic blood pressure values were included if participants had at least 2 valid measurements. Further details of these measures are described elsewhere.[25](#jah34147-bib-0025){ref-type="ref"}, [35](#jah34147-bib-0035){ref-type="ref"}

At the time of assessment, waveforms were assessed using the in‐built quality control software in the SphygmoCor XCEL. After study completion, waveforms were further reviewed by 2 trained analysts and were excluded if they did not meet quality control standards. To assess interrater reliability, 112 individually recorded waves from a random sample of 40 participants (20 children and 20 adults) from the CheckPoint study database were presented blindly to 2 analysts for review. Pulse wave quality ratings given by each analyst (poor, adequate, or good) were compared by calculating the proportion of positive agreement between analysts. Most sample waveforms were of good quality, and none were of poor quality. The overall correlation between analysts was high (*r*=0.99). Automated measurement of carotid‐femoral PWV by SphygmoCor is approved by the US Food and Drug Administration, is extensively standardized across large general populations,[22](#jah34147-bib-0022){ref-type="ref"}, [36](#jah34147-bib-0036){ref-type="ref"}, [37](#jah34147-bib-0037){ref-type="ref"} and is validated against other well‐validated tonometry‐based methods,[38](#jah34147-bib-0038){ref-type="ref"}, [39](#jah34147-bib-0039){ref-type="ref"} as per the ARTERY (Association for Research into Arterial Structure and Physiology) PWV validation guidelines.[40](#jah34147-bib-0040){ref-type="ref"} Published values for interobserver and intraobserver carotid‐femoral PWV variability are 0.30 m/s (SD, 1.25 m/s) and 0.07 m/s (SD, 1.17 m/s), respectively.[41](#jah34147-bib-0041){ref-type="ref"} Further details are in Data [S1](#jah34147-sup-0001){ref-type="supplementary-material"} and are described elsewhere.[25](#jah34147-bib-0025){ref-type="ref"}, [35](#jah34147-bib-0035){ref-type="ref"}

Potential Confounders {#jah34147-sec-0014}
---------------------

Several variables were considered a priori as potential confounders, including body mass index (BMI; kg/m^2^),[42](#jah34147-bib-0042){ref-type="ref"} socioeconomic status,[43](#jah34147-bib-0043){ref-type="ref"} and smoking.[44](#jah34147-bib-0044){ref-type="ref"} Each of these variables has consistently been associated with telomere length, as well as being commonly known risk factors for cardiovascular health. BMI was calculated from height (standard portable stadiometer; IP0955; Invicta, Leicester, UK) and weight (InBody230 bioelectrical impedance analysis scale; Biospace Co Ltd Seoul, South Korea). For children, an age‐ and sex‐adjusted BMI *z* score was calculated using the US Centers for Disease Control and Prevention growth reference charts.[45](#jah34147-bib-0045){ref-type="ref"} As a measure of neighborhood socioeconomic status, we used the Socio‐Economic Indexes for Areas Index of Relative Disadvantage score, which is based on the postcode of domicile of the participating family. This is a standardized score by geographic area, compiled from 2011 Australian Census data to numerically summarize the social and economic conditions of Australian neighborhoods (national mean of 1000 and SD of 100, where higher values represent less disadvantage). Parental current smoking behavior and cigarettes smoked per day were self‐reported at LSAC wave 6. Preexisting conditions were self‐reported (yes/no) by questionnaire at the CheckPoint study assessment, including diabetes mellitus status, heart conditions, hypertension medication, and pacemakers. Further details of these sample measures are described elsewhere.[25](#jah34147-bib-0025){ref-type="ref"}

Other Covariates {#jah34147-sec-0015}
----------------

Other covariates traditionally associated with cardiovascular outcomes were measured using the Nightingale nuclear magnetic resonance metabolomics platform (Helsinki, Finland) from blood serum. These included lipids (total cholesterol, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, and triglycerides), glucose, and the inflammation marker of glycoprotein acetyls. Further details of this platform and method are extensively described elsewhere.[46](#jah34147-bib-0046){ref-type="ref"}

Statistical Analysis {#jah34147-sec-0016}
--------------------

Stata 14.2 (StataCorp, College Station, TX) was used for all analyses. Continuous variables are presented as means and SD, whereas dichotomous variables are presented as percentages.

Associations of telomere length with vascular measures were examined by linear and logistic regression models, in children and adults separately. Assumptions for linear regression were examined using histograms and scatterplots, and they showed no discernible outliers and minimal right skewing for child\'s and adult\'s telomere length. For aim 1, linear regression models fitted continuous telomere length as the independent variable and continuous data on vascular measures as dependent variables in separate models. For aim 2, logistic regression models fitted continuous telomere length as the independent variable and elevated carotid IMT, carotid‐femoral PWV, and reduced carotid elasticity as the dependent variables in separate models. Elevated carotid IMT and elevated carotid‐femoral PWV were defined internally as \>75th percentile for the sample. Reduced carotid elasticity was defined internally as \<25th percentile.

For both aims, model 1 included adjustments for the potential lifelong confounders of sex and age, as well as for sample type (ie, whole blood or blood clot) to account for any effects of the early change in the sample collection protocol from blood clots to whole blood. Adjusted analyses included the covariates as independent variables. Model 2 additionally included adjustments for the additional potential confounders of BMI and Socio‐Economic Indexes for Areas Index of Relative Disadvantage score, plus smoking status, for adults. In model 3, we further adjusted for systolic blood pressure, lipids, glucose, and glycoprotein acetyls. Finally, we conducted sensitivity analysis that did the following: (1) further adjusted for preexisting conditions, (2) adjusted for mean arterial pressure or diastolic blood pressure in place of systolic blood pressure, and (3) stratified by, rather than adjusted for, sample type. Sensitivity analyses showed similar results to those presented below (data not shown; available on request).

Results {#jah34147-sec-0017}
=======

A total of 1874 parent‐child dyads participated in the CheckPoint study ([Figure](#jah34147-fig-0001){ref-type="fig"}). As venous blood was not collected at home visits (n=364 dyads), these participants were not included in the current analysis. Venous blood (whole blood or blood clot) was available for 1216 children and 1350 adults. Telomere length data were generated for 1206 children (99.2%) and 1343 adults (99.5%).

Sample Characteristics {#jah34147-sec-0018}
----------------------

Participant characteristics are displayed in Table [1](#jah34147-tbl-0001){ref-type="table"}. Children and adults were, on average, aged 11 years (SD, 0.5 years) and 44 years (SD, 5.1 years), respectively. Adults were predominantly mothers (n=1168; 87%), whereas there were approximately equal numbers of boys and girls. Participants came from slightly less disadvantaged and more homogeneous areas compared with the national average (mean Socio‐Economic Indexes for Areas Index of Relative Disadvantage score, 1026 \[SD, 61\] versus 1000 \[SD, 100\]). Child and adult BMI scores were similar to those of the current Australian population, as recorded by the Australian Bureau of Statistics, with ≈1 in 4 children and 2 in 3 adults overweight or obese.[47](#jah34147-bib-0047){ref-type="ref"} Compared with the general Australian population rates for similar age ranges, adults' self‐report of diabetes mellitus (2.4% versus 4%) and being a current smoker (8% versus 16%) were lower[47](#jah34147-bib-0047){ref-type="ref"} but CVD (2.2% versus 2.5%) was comparable.[47](#jah34147-bib-0047){ref-type="ref"}

###### 

Summary Characteristics of Children and Adults

  Participant Characteristic                 Children      Adults
  ------------------------------------------ ------------- -------------
  Total No.                                  1206          1343
  Age, y                                     11 (0.5)      44 (5.1)
  Female sex, %                              51            87
  Height, cm                                 154 (8)       167 (8)
  Body mass index, kg/m^2^                   19 (3)        28 (6)
  Body mass index *z* score                  0.3 (1)       ···
  Disadvantage score                         1026 (62)     1026 (61)
  Current smoking, %                         ···           8.2
  Cigarettes smoked per day                  ···           2.6 (0.14)
  Preexisting conditions, %                                
  Diabetes mellitus                          0.1           2.4
  Heart condition                            ···           2.2
  Hypertension medication                    ···           5.1
  Pacemakers                                 ···           0.1
  Systolic blood pressure, mm Hg             108 (8)       120 (13)
  Diastolic blood pressure, mm Hg            63 (6)        74 (9)
  Lumen diameter, mm                         5.9 (0.5)     5.8 (0.6)
  HDL cholesterol, mg/dL                     54 (10)       56 (14)
  LDL cholesterol, mg/dL                     25 (6)        30 (8)
  Total cholesterol, mg/dL                   73 (12)       86 (16)
  Triglycerides, mg/dL                       105 (49)      132 (75)
  Glucose, mg/dL                             89 (14)       88 (19)
  Glycoprotein acetylation, mmol/L           0.99 (0.13)   1.04 (0.17)
  Telomere length (T/S ratio)                1.09 (0.55)   0.81 (0.38)
  Vascular outcomes                                        
  Carotid intima‐media thickness, μm         580 (46)      663 (97)
  Carotid‐femoral pulse wave velocity, m/s   4.4 (0.5)     7.0 (1.1)
  Carotid elasticity, % per 10‐mm Hg         4.8 (0.9)     2.4 (0.6)

Data are presented as mean (SD) or percentage. HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein; T/S ratio, telomeric genomic DNA (T)/β‐globin single‐copy gene (S).

Children had longer telomeres (higher T/S ratio, 1.09; SD, 0.55) than adults (0.81; SD, 0.38).[33](#jah34147-bib-0033){ref-type="ref"} Adults, on average, had thicker carotid IMT than children (663 \[SD, 97\] μm versus 580 \[SD, 46\] μm) and stiffer vessels, as shown in faster carotid‐femoral PWV (7.0 \[SD, 1.1\] m/s versus 4.4 \[SD, 0.5\] m/s) and lower carotid elasticity (2.4% \[SD, 0.6%\] versus 4.8% \[SD, 0.9%\] per 10‐mm Hg). Further details of the distributions of vascular phenotypes are in Figure [S1](#jah34147-sup-0001){ref-type="supplementary-material"} and were previously described.[34](#jah34147-bib-0034){ref-type="ref"}, [35](#jah34147-bib-0035){ref-type="ref"} Adults with self‐reported diabetes mellitus and hypertension medication use had thicker carotid IMT, faster carotid‐femoral PWV, and lower carotid elasticity (Table [S2](#jah34147-sup-0001){ref-type="supplementary-material"}). Vascular phenotypes were similar in current smokers and nonsmokers, noting that this may be limited by lack of smoking history. Telomere length was not related with diabetes mellitus, current smoking, and hypertension medication in adults (Table [S3](#jah34147-sup-0001){ref-type="supplementary-material"}). Higher blood pressure was associated with longer telomeres in adults, but not in children (Table [S4](#jah34147-sup-0001){ref-type="supplementary-material"}).

Association of Telomere Length With Carotid IMT, Carotid‐Femoral PWV, and Carotid Elasticity {#jah34147-sec-0019}
--------------------------------------------------------------------------------------------

In linear regression models adjusted for age, sex, and sample type, children\'s T/S ratio showed little association with vascular measures (Table [2](#jah34147-tbl-0002){ref-type="table"}; model 1). Similarly, adult T/S ratio showed little association with carotid IMT or carotid‐femoral PWV (Table [2](#jah34147-tbl-0002){ref-type="table"}; model 1). However, in adults, longer telomeres were associated with greater carotid elasticity (0.14% per 10‐mm Hg higher for each additional unit of T/S ratio; 95% CI, 0.04%--0.2%). This is equivalent to an effect size of 0.09 SDs higher carotid elasticity for each SD increase in T/S ratio. This association persisted after adjustments for sex, age, sample type, BMI, Socio‐Economic Indexes for Areas Index of Relative Disadvantage score, and smoking status (0.13% per 10‐mm Hg; 95% CI, 0.05%--0.20%; Table [2](#jah34147-tbl-0002){ref-type="table"}; model 2), as well as for systolic blood pressure, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides, glucose, and glycoprotein acetyls (0.09% per 10‐mm Hg; 95% CI, 0.003%--0.18%; Table [2](#jah34147-tbl-0002){ref-type="table"}; model 3).

###### 

Association of Telomere Length With Carotid IMT, Carotid‐Femoral PWV, and Carotid Elasticity, in Children and Adults

  Outcome                                          Children   Adults                                                                        
  ------------------------------------------------ ---------- ----------------------- ------ ------ ------ ------------------------- ------ -------
  Model 1[a](#jah34147-note-0004){ref-type="fn"}                                                                                            
  Carotid IMT, μm                                  1193       4.11 (−1.21 to 9.4)     0.04   0.13   1203   −0.85 (−14.31 to 12.61)   0.16   0.90
  Carotid‐femoral PWV, m/s                         1167       −0.01 (−0.07 to 0.06)   0.06   0.86   1110   −0.10 (−0.27 to 0.07)     0.10   0.23
  Carotid elasticity, % per 10‐mm Hg               1083       −0.04 (−0.15 to 0.06)   0.01   0.42   1040   0.14 (0.04 to 0.24)       0.12   0.007
  Model 2[b](#jah34147-note-0005){ref-type="fn"}                                                                                            
  Carotid IMT, μm                                  1192       4.67 (−0.64 to 9.99)    0.05   0.09   1198   0.46 (−12.71 to 13.64)    0.20   0.95
  Carotid‐femoral PWV, m/s                         1166       0.01 (−0.05 to 0.07)    0.13   0.68   1106   −0.12 (−0.28 to 0.04)     0.24   0.13
  Carotid elasticity, % per 10‐mm Hg               1082       −0.06 (−0.17 to 0.05)   0.04   0.26   1035   0.13 (0.04 to 0.22)       0.26   0.006
  Model 3[c](#jah34147-note-0006){ref-type="fn"}                                                                                            
  Carotid IMT, μm                                  1082       4.89 (−0.60 to 10.37)   0.07   0.08   1082   1.17 (−12.60 to 14.94)    0.25   0.87
  Carotid‐femoral PWV, m/s                         1070       0.02 (−0.04 to 0.08)    0.16   0.57   1031   −0.09 (−0.23 to 0.06)     0.40   0.24
  Carotid elasticity, % per 10‐mm Hg               1037       −0.09 (−0.19 to 0.02)   0.15   0.11   1003   0.09 (0.003 to 0.18)      0.36   0.04

IMT indicates intima‐media thickness; PWV, pulse‐wave velocity; *R* ^2^, value for the linear regression model.

Model 1 was adjusted for sex, age, and sample type.

Model 2 was additionally adjusted for body mass index, Socio‐Economic Indexes for Areas Index of Relative Socioeconomic Disadvantage score, plus smoking status for adults.

Model 3 was additionally adjusted for brachial systolic blood pressure, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides, glucose, and glycoprotein acetylation.

In both adults and children, adjusted logistic regression models showed little evidence of a difference in the odds of elevated carotid IMT, elevated carotid‐femoral PWV, or reduced carotid elasticity for each unit higher T/S ratio (Table [3](#jah34147-tbl-0003){ref-type="table"}).

###### 

Odds Ratio for Elevated Carotid IMT, Elevated Carotid‐Femoral PWV, and Reduced Carotid Elasticity for 1 Unit Higher T/S Ratio, in Children and Adults

  Outcome                                                             Children   Adults                                                
  ------------------------------------------------------------------- ---------- ------------------- ------ ------ ------------------- ------
  Model 1[a](#jah34147-note-0008){ref-type="fn"}                                                                                       
  Elevated carotid IMT                                                1193       1.23 (0.94--1.61)   0.13   1203   0.94 (0.65--1.37)   0.77
  Elevated carotid‐femoral PWV                                        1167       0.82 (0.60--1.13)   0.23   1110   0.88 (0.59--1.30)   0.56
  Reduced carotid elasticity[a](#jah34147-note-0008){ref-type="fn"}   1083       0.99 (0.73--1.32)   0.92   1040   0.84 (0.55--1.30)   0.44
  Model 2[b](#jah34147-note-0009){ref-type="fn"}                                                                                       
  Elevated carotid IMT                                                1192       1.27 (0.97--1.66)   0.08   1198   0.98 (0.67--1.44)   0.92
  Elevated carotid‐femoral PWV                                        1166       0.88 (0.63--1.23)   0.47   1106   0.83 (0.54--1.28)   0.40
  Reduced carotid elasticity                                          1082       1.02 (0.76--1.38)   0.91   1035   0.83 (0.52--1.32)   0.42
  Model 3[c](#jah34147-note-0010){ref-type="fn"}                                                                                       
  Elevated carotid IMT                                                1082       1.26 (0.95--1.68)   0.11   1082   1.03 (0.66--1.61)   0.89
  Elevated carotid‐femoral PWV                                        1070       0.97 (0.68--1.38)   0.86   1031   0.73 (0.43--1.24)   0.25
  Reduced carotid elasticity                                          1037       1.16 (0.84--1.58)   0.37   1033   1.03 (0.61--1.74)   0.92

Elevated carotid IMT defined as \>75th percentile, elevated carotid‐femoral PWV defined as \>75th percentile, and reduced carotid elasticity defined as \<25th percentile. IMT indicates intima‐media thickness; PWV, pulse‐wave velocity; T/S ratio, telomeric genomic DNA (T)/β‐globin single‐copy gene (S).

Model 1 was adjusted for sex, age, and sample type.

Model 2 was additionally adjusted for body mass index, Socio‐Economic Indexes for Areas Index of Relative Socioeconomic Disadvantage score, plus smoking status for adults.

Model 3 was additionally adjusted for brachial systolic blood pressure, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides, glucose, and glycoprotein acetylation.

Discussion {#jah34147-sec-0020}
==========

Main Findings {#jah34147-sec-0021}
-------------

In the present study, we hypothesized that telomere attrition is an upstream event of cardiometabolic disease and, as such, evidence for shortened telomeres will be present in mid‐aged adults and children in association with preclinical phenotypes of poorer cardiovascular health. Furthermore, given the progressive nature of the proposed association, we predicted that the strength of association between telomere length and phenotypes will be stronger in adults relative to their children. We tested this in a population‐based cohort of children and mid‐life adults and found no convincing evidence of associations between shorter telomeres and adverse vascular phenotypes at either age, other than a small association between longer telomere length and increased carotid elasticity in adults.

Strengths and Limitations {#jah34147-sec-0022}
-------------------------

Strengths of our study include the objective examination of carotid IMT, carotid‐femoral PWV, and carotid elasticity with high reliability and the T/S measurements showing low replicate variation. We are confident in interpreting the child and adult findings within the same study because they were assessed at the same time point with the same protocols, equipment, and staff. For telomere length, we used a quantitative real‐time polymerase chain reaction method that correlates strongly with the gold standard terminal restriction fragment analysis.[31](#jah34147-bib-0031){ref-type="ref"} However, although well suited for large epidemiological studies, this method does not quantify absolute, chromosome‐specific, or vascular tissue‐specific telomere length. Also, the capacity of telomere length derived from blood as a surrogate for telomere length within the vasculature itself is uncertain; however, there is evidence that telomere length is highly conserved between tissues.[48](#jah34147-bib-0048){ref-type="ref"}, [49](#jah34147-bib-0049){ref-type="ref"} Differential uptake in LSAC and attrition in CheckPoint study led to our sample including few fathers and few less disadvantaged families than in the general Australian population. Thus, if such children and adults had both shorter telomeres and poorer vascular outcomes, this could have altered estimates and/or their precision. Finally, the cross‐sectional design precluded conclusions about temporal associations.

Interpretation in Light of Other Studies {#jah34147-sec-0023}
----------------------------------------

### Telomere length, vascular structure, and atherosclerosis {#jah34147-sec-0024}

We found little evidence of an association between telomere length and carotid IMT. This is consistent with several prior reports showing no or only marginal associations.[17](#jah34147-bib-0017){ref-type="ref"}, [19](#jah34147-bib-0019){ref-type="ref"}, [20](#jah34147-bib-0020){ref-type="ref"}, [50](#jah34147-bib-0050){ref-type="ref"}, [51](#jah34147-bib-0051){ref-type="ref"}, [52](#jah34147-bib-0052){ref-type="ref"} For example, in healthy adults, telomere length was not independently associated with carotid IMT[19](#jah34147-bib-0019){ref-type="ref"} (n=2509; age range, 35--55 years) and atherosclerosis in the carotid arteries (n=1459; age range, 40--54 years).[20](#jah34147-bib-0020){ref-type="ref"} Together, these studies suggest that associations between telomere length and vascular structure appear primarily later in adulthood. Moreover, there is evidence that shortened telomere length is more reliably associated with patients with CVD. For example, shorter telomere length has been observed in aortic tissues with atherosclerotic lesions, compared with tissues without atherosclerotic lesions;[8](#jah34147-bib-0008){ref-type="ref"} and in another study, telomere length was associated with advanced‐state, but not with early‐stage, atherosclerosis.[51](#jah34147-bib-0051){ref-type="ref"} Telomere shortening might play a role late in the pathogenesis of CVD, in late adulthood when the effects of cumulative burden over the life course begin to manifest. This hypothesis would be consistent with current knowledge, in which the cellular senescence induced by the aging process is known to trigger the progressive deterioration of vascular functionality with age.[53](#jah34147-bib-0053){ref-type="ref"}

Our findings also align with evidence that shortened telomere length is associated with vascular phenotypes in those with greater CVD risk[6](#jah34147-bib-0006){ref-type="ref"} (eg, in elderly populations; mean age, 74.2 years; SD, 5.2 years),[17](#jah34147-bib-0017){ref-type="ref"} diabetic subjects,[9](#jah34147-bib-0009){ref-type="ref"}, [54](#jah34147-bib-0054){ref-type="ref"} and obese men.[50](#jah34147-bib-0050){ref-type="ref"} Interestingly, a recent meta‐analysis of 5566 patients with coronary artery disease found an overall higher risk for coronary artery disease in older subjects (≥70 years), compared with younger subjects (\<70 years; relative risk, 1.9 versus 1.5), with respect to individuals in the shortest telomere tertile compared with those in the longest telomere tertile.

### Telomere length, vascular function, and arterial stiffness {#jah34147-sec-0025}

There was little evidence of an association between telomere length and carotid‐femoral PWV in children or adults. Several recent studies have reported an association between shorter telomeres and faster carotid‐femoral PWV, but most have been in older adults (\>50 years), were limited by modest sample sizes (range, 49--303 individuals),[21](#jah34147-bib-0021){ref-type="ref"}, [37](#jah34147-bib-0037){ref-type="ref"}, [54](#jah34147-bib-0054){ref-type="ref"} and were predominately in men.[21](#jah34147-bib-0021){ref-type="ref"}, [55](#jah34147-bib-0055){ref-type="ref"} For example, Benetos et al showed that shorter telomere length was significantly associated with faster carotid‐femoral PWV in men (n=120; mean age, 55 years; *r*=−0.14), but not in women (n=73; mean age, 56 years; *r*=−0.05).[55](#jah34147-bib-0055){ref-type="ref"} Similar results were also found in a study of healthy Chinese men (n=112; mean age, 56 years).[21](#jah34147-bib-0021){ref-type="ref"} We cannot tell whether our lack of association between telomere length and carotid‐femoral PWV reflects our preponderance of women or the younger age in our sample. Interestingly, previous findings suggest that age significantly modifies the relationship between telomere length and carotid‐femoral PWV in healthy individuals,[22](#jah34147-bib-0022){ref-type="ref"} an effect not observed in our study.

In summary, we report a novel, albeit small, association between telomere length and carotid elasticity in adults, which remained after adjustment for a priori specified confounders. Although speculative at this point, this suggests a possibility that cellular senescence might contribute to vascular function, through the elasticity of the vasculature. One hypothesis might be that the secretory phenotype of senescent vascular cells might promote vascular degeneration through the destabilization of extracellular matrix, elastin, collagen, and smooth muscle,[12](#jah34147-bib-0012){ref-type="ref"} thus modifying the elasticity of the carotid artery. However, we suspect that it would also have effects on overall arterial stiffness and, thus, affect carotid‐femoral PWV, which we did not find. This discordance warrants further investigation. We note that although vascular structure and function are considered to be related, they ultimately measure different properties of the arterial tree, both likely affected by risk factors in a nonuniform manner. It has been documented that functional changes precede the development of structural alterations in the vasculature.[23](#jah34147-bib-0023){ref-type="ref"}

Clinical Implications, Unanswered Questions, and Future Direction {#jah34147-sec-0026}
-----------------------------------------------------------------

Our findings, if replicated in other settings, question the clinical utility of measuring telomere length in healthy relatively young populations. The magnitude of the cross‐sectional association between telomere length and carotid elasticity observed among adults was small. In addition, the European Society of Hypertension and the European Society of Cardiology noted that a carotid IMT of \>900 μm and a carotid‐femoral PWV of \>12 m/s are associated with increased CVD risk,[56](#jah34147-bib-0056){ref-type="ref"} thresholds not reached by our relatively healthy cohort of children and adults. This suggests that the magnitude of the associated changes is unlikely to represent clinically significant differences on CVD risk, especially in largely healthy populations of children or mid‐life adults. However, telomere length might be of greater clinical relevance at an advanced age or in association with more pronounced vascular pathological features. Moreover, it is possible that such associations could be important longitudinally, such that the rate of telomere attrition, rather than cross‐sectional telomere length per se, may be a more clinically important cardiovascular risk marker. Indeed, in a recent British longitudinal study (baseline n=2611; mean age, 53 years; follow‐up age range, 60--64 years), an association was observed between the rate of telomere attrition and thicker carotid IMT at 60 to 64 years, despite limited cross‐sectional associations.[18](#jah34147-bib-0018){ref-type="ref"} Future studies should consider longitudinal evaluation with repeated telomere sampling to assess whether telomere attrition over time is associated with vascular phenotypes and cardiovascular events.

We cannot exclude the possibility that our findings may have arisen by chance, and might be explained by factors beyond the scope of this study, including genetic variation and other unmeasured environmental exposures. The ability of carotid ultrasounds and tonometry to effectively measure meaningful changes in vascular structure and function in healthy individuals is also uncertain. In particular, the predictive value of carotid IMT measurement in children aged 11 to 12 years without CVD risk remains unclear.[57](#jah34147-bib-0057){ref-type="ref"}

Conclusion {#jah34147-sec-0027}
==========

In a healthy cohort of children and mid‐life adults, we report limited evidence that cellular senescence, as measured by telomere length, is associated with vascular structure or function in children or adults. The novel small association between longer telomere length and higher carotid elasticity in adults is interesting, supporting our hypothesis that telomere length may be on the mechanistic pathway toward impaired vascular function; however, the strength of the association could equally be caused by chance and, hence, requires replication. Although telomere length may be important for individuals at intermediate to high CVD risk or those at advanced disease stages, as previously reported, cross‐sectional telomere length assessment appears to have limited clinical value for CVD risk in healthy populations, particularly at younger ages. The interaction between telomere dynamics and vascular phenotypes across the life course is multifaceted, with contributions from genetic variation and environmental exposures. Further longitudinal investigations, with repeated telomere and vascular phenotypic sampling, are warranted.
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